Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

ACE-inhibitors and atherosclerosis.

E Ambrosioni1, S Bacchelli, D Degli Esposti

  • 1Third Department of Internal Medicine, University of Bologna, Italy.

European Journal of Epidemiology
|May 1, 1992
PubMed
Summary

Angiotensin converting enzyme (ACE) inhibitors show potential in preventing atherosclerosis development in animal models. These drugs may suppress vascular proliferation and reduce atherosclerotic lesions, though clinical significance remains unknown.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronic metal contamination shapes the size structure of Gammarus fossarum populations in French headwater rivers.

Ecotoxicology (London, England)·2024
Same author

Screening of hypercortisolism among patients with hypertension: an Italian nationwide survey.

Journal of endocrinological investigation·2024
Same author

Corrigendum to "Natural mutations of human XDH promote the nitrite (NO<sub>2</sub><sup>-</sup>)-reductase capacity of xanthine oxidoreductase: A novel mechanism to promote redox health?" [Redox Biol. 4 (67) (2023) 102864].

Redox biology·2023
Same author

Natural mutations of human XDH promote the nitrite (NO<sub>2</sub><sup>-</sup>)-reductase capacity of xanthine oxidoreductase: A novel mechanism to promote redox health?

Redox biology·2023
Same author

Perspectives on improving blood pressure control to reduce the clinical and economic burden of hypertension.

Journal of internal medicine·2023
Same author

Impact of simultaneous management of hypertension and hypercholesterolemia with ACE inhibitors and statins on cardiovascular outcomes in the Brisighella Heart Study: A 8-year follow-up.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2022

Area of Science:

  • Cardiovascular Research
  • Pharmacology

Background:

  • The renin-angiotensin system (RAS) plays a role in atherogenesis, with angiotensin II influencing vascular smooth muscle cell growth.
  • Experimental data suggest the presence and specific actions of RAS components within the vascular wall.

Purpose of the Study:

  • To investigate the effect of angiotensin converting enzyme (ACE) inhibition on the development of atherosclerosis in animal models.
  • To explore potential mechanisms by which ACE inhibitors might exert anti-atherosclerotic effects.

Main Methods:

  • Studies utilized various animal models, including rats, Watanabe heritable hyperlipidemic rabbits, and cholesterol-fed monkeys.
  • Specific ACE inhibitors like captopril and cilazapril were administered to assess their impact on vascular injury, cholesterol levels, and lesion progression.

Related Experiment Videos

Main Results:

  • ACE inhibition prevented myointimal proliferation after vascular injury in rats.
  • Captopril reduced aortic cholesterol and lesion coverage in rabbits, and slowed lesion progression in monkeys.
  • Converting enzyme inhibitors demonstrated a role in reducing aortic and microvascular growth in both hypertensive and normotensive rats.

Conclusions:

  • ACE inhibitors may suppress atherosclerosis development in animals by preventing angiotensin II-induced vascular proliferation.
  • Potential roles of blood pressure reduction and other mechanisms, such as effects on sympathetic activity and growth factors, are considered.
  • The clinical significance of these experimental findings is currently unknown.